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Abstract: Cellular glycosylation plays a pivotal role in several molecular mechanisms controlling
cell–cell recognition, communication, and adhesion. Thus, aberrant glycosylation has a major impact
on the acquisition of malignant features in the tumor progression of patients. To mimic these in vivo
features, an innovative high-throughput 3D spheroid culture methodology has been developed for
gastric cancer cells. The assessment of cancer cell spheroids’ physical characteristics, such as size,
morphology and solidity, as well as the impact of glycosylation inhibitors on spheroid formation
was performed applying automated image analysis. A detailed evaluation of key glycans and
glycoproteins displayed by the gastric cancer spheroids and their counterpart cells cultured under
conventional 2D conditions was performed. Our results show that, by applying 3D cell culture
approaches, the model cell lines represented the differentiation features observed in the original
tumors and the cellular glycocalix underwent striking changes, displaying increased expression of
cancer-associated glycan antigens and mucin MUC1, ultimately better simulating the glycosylation
phenotype of the gastric tumor.
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1. Introduction
Gastric cancer is the third leading cause of cancer-related deaths worldwide, and despite the
efforts performed to find novel treatments, surgery remains the only curative treatment for localized
gastric cancer [1]. However, large numbers of gastric cancer patients are diagnosed when metastases
are already present, and then curative attempts are vain. At present, chemotherapy is used as first-line
treatment for these patients. Several drugs with higher specificity are currently being developed, but
good in vitro models that simulate in vivo physiology are required to assess their efficacy.
The culture of mammalian cells has been classically performed in two-dimensional (2D) setups.
The increasing knowledge of tumor biology, in which architecture plays an important role, has led
to the development of novel approaches allowing improved simulation of physiological conditions.
These systems can mimic the complex structures of different types of tissue in the mammalian body,
helping to overcome the limited prediction accuracy of classical 2D-based screening assays [2,3].
Multicellular spheroids methods, where cells cluster together to form unique entities, have been
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demonstrated to be promising for the screening of novel drugs [4]. Different approaches have
been developed for the formation of multicellular tumor spheroids (MCTS) [5]. Some conventional
methodologies include plate coating with polyHEMA or the hanging-drop system, both of which are
labor-intensive. As an emerging field with a broad range of applications, innovative methodologies
are continuously developed, focusing on exploiting automation and high-throughput capacity. In this
regard, microfluidic platforms that allow the formation of a thousand MCTS within a chip have been
recently reported [6,7].
The cell glycocalyx is known to be of utmost relevance for a large variety of biological processes,
such as cell–cell recognition, communication, intercellular adhesion, leukocyte trafficking and innate
immunity [8,9]. In this regard, alterations in glycosylation occur in different diseases including cancer,
playing a pivotal role in malignant transformation and tumor progression [9,10]. For this reason,
understanding the role of glycosylation in the formation and maturation of multicellular spheroids is
crucial in order to use these models for biological and screening studies. In this work, we optimized
three-dimensional (3D) spheroid culture conditions for four commonly used gastric cancer cell lines
(AGS, MKN45, MKN74, and NCI-N87) with two distinct methods, and characterized in depth the
spheroid glycosylation profile as opposed to 2D-cultured cells. In addition, we analyzed the effect
of glycosylation inhibition in spheroid development between the four cell line models. To the best
of our knowledge, this is the first work addressing the glycosylation displayed by gastric cancer
cell spheroids.
2. Results
2.1. Gastric Cancer Spheroids Morphological Features and Maturation
Different amounts of the four gastric cancer cell lines, AGS, MKN45, MKN74, and NCI-N87, were
seeded to assess the number of cells required for MCTS formation. It is considered that spheroids
with a diameter between 200 and 500 µm develop decreasing gradients of oxygen, nutrients, and
catabolites toward the innermost cells; therefore, mimicking tumor physiology [11]. Previous studies
have shown that, after four days, isolated cells can group and form MCTS [4]. For an objective
evaluation of MCTS features, namely, size, compactness, and roundness, an automated image-analysis
system was set up (Figure S1). This analysis allowed us to differentiate between loosely formed cell
aggregates and different qualities of MCTS. In this regard, AGS, a cell line lacking functional cell–cell
adhesion molecule E-cadherin [12,13] formed the loosest spheroids as shown by their large size and
low compactness in a time-point- and cell-number-independent manner. MKN45, a cell line known
to form homophilic cell–cell connections, formed loosely packed MCTS, as indicated by the slightly
smaller size and higher density than AGS aggregates. NCI-N87 formed the tightest MCTS of the
evaluated cell lines, as shown by the small size and 100% compactness, even with low cell numbers.
Interestingly, MKN74 also formed small and compact MCTS, but this cell line’s MCTS showed low
roundness values. Low roundness indicates a high degree of differentiation and organization when
these cells grow as spheroids, a feature that cannot be observed when cells are grown in 2D (Figure 1,
Figure S2).
Our data show that the two systems used for MCTS formation, ultralow attachment (ULA) and
3D Petri Dish® resulted in gastric MCTS displaying similar roundness values, but smaller and higher
compact MCTS when using the 3D Petri Dish® approach (Figure 1). These results are consistent with
the fact that the maximal diameter of the wells created with the 3D Petri Dish® system was 800 µm,
about 500,000 µm2 of area. In this regard, the 3D Petri Dish® is not only a high-throughput system, but
also helps the formation of spheroids by forcing the cells to interact in a limited space.
Molecules 2018, 23, 2815 3 of 12
Molecules 2018, 23, x 3 of 12 
 
 
Figure 1. Comparison between two standardized methodologies (ULA and 3D Petri Dish®) for 
generation, imaging, and automatized analysis of gastric multicellular tumor spheroids (MCTS). (A) 
Representative images of gastric MCTS and the results of automated image analysis for (B) size, (C) 
solidity, and (D) roundness, generated using ULA 96-well round-bottomed plates. (E) Representative 
images of MCTS and the corresponding results of automated image analysis for (F) size, (G) solidity, 
and (H) roundness, generated with the 3D Petri Dish® technology (MICROTISSUES®). Values are 
means ± SD of at least n = 3 (ULA) and n = 9 (3D Petri Dish®). For each condition, three independent 
experiments were performed. Scale bar represents 200 µm. 
2.2. Glycosylation Affects Multicellular Spheroid Growth 
The role of glycosylation in MCTS generation was assessed by subjecting the gastric MCTS to 
two different inhibitors of glycosylation using the ULA plates: tunicamycin, which blocks the 
synthesis of N-glycans; and swainsonine, which prevents the formation of complex N-glycans. The 
results disclosed that MCTS growth is restrained when altering glycosylation (Figure 2). At higher 
concentrations of tunicamycin (1–5 µg/mL), where the N-glycosylation of the proteins at the 
endoplasmic reticulum is precluded, strong reduction in size was observed in the four cell lines. On 
the other hand, the effect of swainsonine, a milder inhibitor of glycosylation, as well as the treatment 
with low concentrations of tunicamycin (0.01–0.1 µg/mL) only showed to affect the growth of the 
AGS MCTS. Altogether supporting a protective effect of the cells grown in 3D. Since AGS cells do 
not form cell–cell contacts and display the lowest compactness, this protective effect is lost in the AGS 
cells (Figure 2). In order to address cell toxicity, we evaluated cell proliferation and the apoptotic 
status of the treated spheroids. Our results showed that, by treating loose spheroids with 
swainsonine, no effect was observed on either cell viability or apoptosis. For treatment with 
Figure 1. Comparison between two standardized methodologies (ULA and 3D Petri Dish®) for
generation, imaging, and automatized alysis of gastric multicellular tumor spheroids (MCTS).
(A) Representative images of gastric MCTS and the res s of automated image analysis for
(B) size, (C) sol dity, and (D) roundness, gene ated using ULA 96-well round-bottomed plates.
(E) Representative imag of MCTS and the corresponding results of automated image analysis
for (F) size, (G) solidity, and (H) roundness, generated with the 3D Petri Di h® technolog
(MICROTISSUES®). Values are means ± SD of at least n = 3 (ULA) and n = 9 (3D Petri Dish®).
For each condition, three independent experiments were performed. Scale bar represents 200 µm.
2.2. Glycosylation Affects Multicellular Spheroid Growth
The role of glycosylation in MCTS generation was assessed by subjecting the gastric MCTS
to two different inhibitors of glycosylation using the ULA plates: tunicamycin, which blocks the
synthesis of N-glycans; and swainsonine, which prevents the formation of complex N-glycans.
The results disclosed that MCTS growth is restrained when altering glycosylation (Figure 2). At
higher concentrations of tunicamycin (1–5 µg/mL), where the N-glycosylation of the proteins at the
endoplasmic reticulum is precluded, strong reduction in size was observed in the four cell lines. On
the other hand, the effect of swainsonine, a milder inhibitor of glycosylation, as well as the treatment
with low concentrations of tunicamycin (0.01–0.1 µg/mL) only showed to affect the growth of the AGS
MCTS. Altogether supporting a protective effect of the cells grown in 3D. Since AGS cells do not form
cell–cell contacts and display the lowest compactness, this protective effect is lost in the AGS cells
(Figure 2). In order to address cell toxicity, we evaluated cell proliferation and the apoptotic status of
the treated spheroids. Our results showed that, by treating loose spheroids with swainsonine, no effect
was observed on either cell viability or apoptosis. For treatment with tunicamycin, cell proliferation
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was abrogated and cell death was revealed. On the other hand, compact spheroids showed, for both
inhibitors, similar proliferative and apoptotic status as the control. Altogether, these results corroborate
the protective effect attributed to strong cell–cell contacts observed in compact MCTS (Figure S3).
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Figure 2. Glycosylation interference analysis for gastric spheroid formation. Multicellular tumor
spheroids ere gro n for five days and treated with different concentrations of glycosylation inhibitor
swainsonine or tunicamycin at different time points. Values represent variation in size at each time
point in comparison to the value at day 5. Values are means ± SD of at least n = 3 spheroids. For each
condition, two independent experiments were performed.
2.3. Glycosylation Profile in Gastric Multicellular Tumor Spheroids Differs from Cells Cultured in a Monolayer
The gastric MCTS were subjected to detailed analysis using a panel of lectins and glycan-directed
antibodies to analyze the glycosylation MCTS profile and compare it with the counterpart cells grown
under conventional 2D cell culture systems. First, hematoxylin and eosin staining of gastric MCTS
showed different histological morphologies (Figure 3). In agreement with the previous results, the AGS
were the least compact aggregates (Figure 3E). Similarly, the MKN45 cell line formed loose spheroids,
although cell–cell contact points were observed (Figure 3F). On the other hand, both the MKN74 and
NCI-N87 cell lines displayed a high degree of cell–cell adhesion and interaction (Figure 3G,H). Special
mention should be given to the higher degree of complexity of the MKN74 leading to the formation of
well-differentiated glandular-like tissue structures.
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The analysis of the glycosylation profile of the four cell lines revealed specific differences when
cells were cultured in 3D in comparison with cells grown in monolayer. The gastric MCTS generated
with the AGS and MKN45 cell lines, displaying a lower degree of compactness, showed a similar
glycosylation pattern as the cells grown in monolayer. On the other hand, MKN74 and NCI-N87,
which engage in extensive cell–cell interaction, disclosed a different pattern of staining, with more
reactivity with lectins, and antibodies detecting glycans at the outer surface of the MCTS and at the
apical membrane of the cancer cells in the glandular-like structures of the MCTS (Figure 4). Different
glycosylation features were particularly marked for the expression of sialyl-Lewis A (SLea) and
sialyl-Lewis X (SLex) in NCI-N87 when comparing the 3D MCTS to their 2D counterparts (Figure 4C).
Additionally, an overall increase of branched structures was observed in all gastric MCTS models
(Figure 4A).
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Figure 4. Glycan profiling of the gastric multicellular tumor spheroids. (A) Immunofluorescent staining
of a panel of lectins and antibodies for glycosylation characterization of gastric cancer cell lines grown
in 2D or 3D cell culture conditions. (B) Aleuria aurantia lectin staining, detecting fucosylation, is shown
as a representative example for the four cell lines. (C) Differential expression of antigens sialyl Lewis A
(SLea) and sialyl Lewis X (SLex) for the NCI-N87 cell line.
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2.4. Gastric Multicellular Tumor Spheroids Better Resemble Gastric Tumor Tissue
The organized arrangement of cells into specific multicellular structures has been proven as
critical for the functional differentiation of cells. In this work, we tested whether gastric cells grown in
3D were capable of producing mucins, which is a characteristic feature of gastrointestinal epithelial
cells [14,15]. As shown in Figure 5, gastric cancer cells grown in monolayer do not express mucins,
but gastric MCTS showed expression of the MUC1 mucin, as detected by two different monoclonal
antibodies. The expression of MUC1 in the MKN74 and NCI-N87 gastric spheroids is located at the
formed glandular-like structures, resembling the phenotype observed in differentiated gastric-cancer
tissue [16,17].
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3D cell culture methods using two different monoclonal antibodies (HMFG1 and HMFG2).
3. Discussion
In the past decades, great efforts have been made to develop cellular model systems that are
capable of recapitulating normal and pathological tissue architectures in order to allow studies on
normal development and disease mechanisms. Cellular processes are highly influenced by architectural
and microenvironmental contexts. Hence, 3D culture models provide invaluable tools to address
fundamental biological questions reproducing biologically relevant conditions [2].
The improved suitability of cancer spheroids has been highlighted by reports that showed
increased resistance of 3D-cultured cancer cells to different antitumoral agents when compared to cells
grown in monolayer, better predicting the outcome of clinical trials [2,18]. In addition, tumors grown
as 3D multicellular spheroids acquire and sustain a multidrug-resistant phenotype in response to acute
drug treatments [19]. Altogether, these models have been shown to be superior over conventional
cell cultures in predicting drug efficiencies. In addition, 3D models show improved adhesion
features [20,21], and secrete extracellular matrix proteins [22,23] implying that tissue organization, cell
adhesion, and the extracellular matrix may synergistically generate apoptosis resistance in metastatic
tumors [24]. In this work, we evaluated the capacity of different gastric cancer cell lines to form 3D
multicellular aggregates, develop complex cellular structures such as glands, and to express glycans
and mucins, which are major components expressed by gastric epithelial cells [15].
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Different approaches have been developed to culture cells in a 3D context, which can mainly be
divided into two classes, scaffold-based and scaffold-free systems [25,26]. In this work, we compared
two scaffold-free systems that allowed the multiplexed evaluation of gastric cancer cell spheroids.
ULA plates are a rapid method to generate multicellular aggregates by preventing the adhesion of
cells to a plastic surface, enforcing the formation of cell–cell interaction. In ULA plates, cells grow in
an unconfined area allowing the generation of spheroids with virtually no space restrictions. The fact
that there is precisely one spheroid per well also facilitates the development of automated systems
for evaluation, including automated plate readers. In contrast, the 3D Petri Dish® approach consists
of a more labor-intensive method, requiring an agarose-mold preparation step that assists in the
generation of spheroids by driving cell interaction in a limited space. Remarkably, the diversity of
available form shapes and sizes enables a more versatile approach for a tailored experimental design.
Importantly, this multiplexed method allows for further processing by paraffin embedding of the
molds containing the spheroids for histological characterizations. In the present study, we combined
the advantages of both methods to evaluate molecular markers as well as to characterize spheroid
morphological features. For the latter, we programmed a plug-in into open-access FIJI software
to analyze the MCTS in both an objective and automated way. The newly developed image system
allowed us to determine not only the size of the spheroids but also to analyze other features, such as the
degree of compactness and the roundness of the MCTS. In particular, for the study with glycosylation
inhibitors, we selected the ULA plates for their easy automation but, more importantly, due to the
possibility that the spheroids would grow in a nonconfined environment, where we could track gastric
MCTS growth or regression. Our results using N-glycosylation inhibitors support the relevance of
glycans in the formation of gastric MCTS; however, further studies addressing O-glycosylation are
warranted for a complete understanding of the role of the glycome in MCTS.
In this study, the comprehensive evaluation of glycosylation features in these models also
generated important glycophenotype information. To prevent artefact results due to different
sample processing, the four gastric cancer cell lines, both in 2D- and 3D-culture conditions, were
paraffin-embedded following the same procedure. The glycophenotype characterization disclosed
a trend of enhanced glycan expression in the 3D MCTS. Among the analyzed glycan determinants,
the SLea and SLex antigens were demonstrated to be highly expressed in many malignant cancers,
and their expression is associated with poor prognosis [9,27,28]. These epitopes are well-known
ligands for selectins, being key players in metastasis development [29,30]. Our results showing
an increase in tumor-associated carbohydrate antigens, such as SLea and SLex, can be due to better
cell differentiation in a specific orientation, reflecting the different stimuli received by the peripheral
cells when compared with the cells in the innermost core region. Our results show that this effect is
directly related to the degree of compactness of the MCTS. Moreover, the formation of MCTS allows
for more differentiated cancer cell lines to develop a glandular-like structure, whose apical membranes
display particularly enriched glycan epitopes and mucins. In order to decipher the specific roles of
the differential glycosylation pattern displayed by the gastric MCTS, functional studies are required.
The expression of mucins is not only relevant in order to recapitulate physiological conditions, but
also has an impact on cell mechanical and rheological properties [31]. In agreement with our results, it
has recently been reported that ovarian cancer cell lines increase MUC1 expression when cultured in
3D conditions [32]. Gastric mucosa expresses different mucins that can experience aberrant expression
of the mucin core protein, as well as de novo expression of glycan structures during malignant
transformation [14,15,33,34], positioning mucins as promising targets in gastric cancer management. In
this regard, over the last three decades more than 200 clinical studies have been conducted evaluating
mucins as a potential tool for prognosis and therapeutic purposes in a wide range of cancers [35–38].
Thus, the development of models reproducing the main biological properties of epithelial surfaces in
the stomach lumen is of utmost interest and relevance.
In addition, apart from demonstrating changes in glycosylation when cells are cultured with
3D methodologies, our results evidenced that, in contrast to 2D cultures, the four gastric cancer cell
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lines grown in 3D cultures remarkably displayed differentiation features that were observed in the
tumors of origin more than 25 years ago [39–41]. In this regard, MKN45 was isolated from a poorly
differentiated adenocarcinoma [39], and MKN74 and NCI-N87 from moderately and well-differentiated
adenocarcinomas of the intestinal subtype, respectively [39,41]. The AGS model, on the other hand,
was isolated from the diffuse subset of a mixed-type gastric carcinoma and thus resembled in 3D
culture typical diffuse-type behavior, lacking cell–cell adhesion features [40]. Our findings agree
with previously reported studies detailing that gastric MCTS recapitulate the growth pattern and
differentiation phenotype of human gastric carcinomas [42].
Overall, the present work has achieved, for the first time, a comprehensive evaluation of the
glycosylation features of gastric cancer cell lines grown in 3D, disclosing the capacity of the presented
approaches and developed models to better recapitulate the in vivo tumor features as compared to
conventional methods. The advances in 3D cell culture techniques could bridge the gap between 2D
studies and in vivo animal models, providing researchers with more accurate in vitro models that
would hasten cancer research and the development of more effective treatments.
4. Materials and Methods
4.1. Cell Culture
Four human gastric cancer cell lines (AGS, MKN45, MKN74, and NCI-N87) were used in this
study. The AGS and NCI-N87 cell lines were obtained from the American Type Culture Collection
(ATCC, Manassas, VA, USA), and the MKN45 and MKN74 cell lines were obtained from the Japanese
Cancer Research Bank (Tsukuba, Japan). Cell line identity was authenticated by standard short
tandem-repeat-based DNA profiling (STR). All cell lines were grown in a monolayer culture and
maintained at 37 ◦C in an atmosphere of 5% CO2, in RPMI 1640 GlutaMAX (Gibco, Thermo-Fisher
Scientific, Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Biowest,
Riverside, MO, USA). Cultured cell lines were routinely tested for mycoplasma contamination by PCR
amplification for mycoplasma pulmonis UAB CTIP, mycoplasma penetrans HF-2, and mycoplasma
synoviae 53.
4.2. Generation of Gastric Multicellular Tumor Spheroids
MCTS formation was conducted by two different approaches. On the one hand, a different
number of cells were either plated in ULA plates (Corning, Thermo-Fisher Scientific) or in 3D Petri
Dish® (MICROTISSUES® technology, MicroTissues Inc., Sigma-Aldrich, St. Louis, MO, USA) following
the protocol described in Reference [23]. Briefly, 12-series agarose micromolds were prepared using
2% agarose in 0.9% of NaCl. The micromolds were placed in 12-well plates and equilibrated with
RPMI 10%FBS before cell seeding. Cell suspension of the desired cell concentration was seeded in the
corresponding micromold. A 30 min incubation period was used for cells to settle into the micromolds,
and additional medium was finally added to the wells. Spheroid formation, both in the ULA plates and
3D Petri Dish®, was monitored with inverted cell culture microscope Leica DMi1 (Leica Microsystems,
Wetzlar, Germany).
4.3. Spheroid Treatment
The cytotoxic activity of the glycosylation inhibitors tunicamycin and swainsonine (both from
Sigma-Aldrich) was followed by monitoring spheroid growth. Aliquots of 1000 AGS cells/well,
250 MKN45 cells/well, 1000 MKN74 cells/well, and 1000 NCI-N87 cells/well were seeded in the
ULA plates. After 5 days, when the gastric MCTS were formed, cells were treated with the inhibitors
diluted in the cell culture medium at concentrations ranging from 0.01 to 5 µg/mL. Control conditions
containing the corresponding amount of DMSO were performed. At day 7, equivalent to 48 h of
treatment, microscope images were acquired, and the gastric MCTS were again treated for 72 h (day 10).
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4.4. Fluorescent Cell Staining
Cells grown in monolayer were detached with a nonenzymatic cell dissociation reagent
(Versene solution, Gibco, Thermo-Fisher Scientific), washed twice with PBS, and fixed with 4% w/v
paraformaldehyde (PFA) for 30 min at RT. Then, cells were resuspended in Richard-Allan Scientific™
HistoGel™ Specimen Processing Gel (Thermo-Fisher Scientific) and paraffin-embedded. At day 5,
after seeding the cells in the 3D Petri Dish®, the medium was replaced. At day 7, the gastric MCTS
were fixed with 4% w/v PFA for 30 min at RT. Fixed samples were paraffin-embedded. The 2D and 3D
blocks containing the four gastric cancer cells were cut into 5 µm sections. Slides were deparaffinised
in xylene and rehydrated in sequentially decreasing ethanol concentrations prior to hematoxylin and
eosin or immunofluorescence staining. In brief, for the immunofluorescence with antibodies, slides
were blocked with nonimmune goat serum in 5% PBS and incubated overnight with the corresponding
dilution of the primary antihuman antibody. Slides were then washed with PBS and incubated with the
secondary antibodies (antimouse IgG Alexa Fluor®-488, antimouse IgM Alexa Fluor®-594 or antirabbit
Alexa Fluor®-488) for 1 h at RT. For fluorescent lectin staining (all from Vector Laboratories, Burlingame,
CA, USA) slides were blocked with PBS, 10% BSA, followed by lectin diluted in PBS for 2 h at RT and
by FITC-conjugated streptavidin diluted 1/1000 in PBS incubations. Nuclei were counterstained with
DAPI and samples were mounted with VectaShield (Vector Laboratories). Sections were imaged with
Zeiss Axio Imager Z1 microscope (Carl Zeiss, Oberkochen, Germany) equipped with an AxioCam
MR ver.3.0.
Fluorescence intensity was scored as weak, medium, or high. For this, images of each antigen
were acquired applying the same camera settings between 2D and 3D. Samples were scored as sparse
whenever they showed less than 10% of positive cells. Evaluation of fluorescence intensity was
performed by two independent specialists.
The antibodies used were: Lewis A (Lea, CA3F4 [43], dilution 1/5); Lewis X (Lex, SH1 [44],
dilution 1/5); Lewis Y (Ley, AH6 [45], dilution 1/5); Sialyl-Lewis A (SLea, CA19-9, Santa Cruz
Biotechnology, Dallas, TX, USA, dilution 1/500); Sialyl-Lewis X (SLex, CSLEX1, DB Pharmingen,
San Jose, CA, USA, dilution 1/80); Silayl-Tn (STn, B72.3 [46], dilution 1/5); MUC1 (HMFG1 and
HMFG2 [47], both diluted 1/4); Cleaved Caspase-3 (D175, 9661, Cell Signaling Technology, Danvers,
MA, USA, dilution 1/800), and Ki67 antibody (ab15580, abcam, Cambridge, United Kingdom, dilution
1/500). The latter two antibodies were used after antigen retrieval with citrate buffer. The lectins used
with their working dilutions and specificity were as follows: Aleuria aurantia lectin (AAL), dilution
1/3000, Fuc6αGlcNAc; Fucα3GlcNAc; Fucα4GlcNAc; Sambucus nigra agglutinin (SNA), dilution
1/3000, Neu5Acα6Galβ4GlcNAc; and Phaseolus Vulgaris Leucoagglutinin lectin (L-PHA), dilution
1/2000, Galβ4GlcNAcβ6(Galβ4GlcNAcβ2)Manα6.
4.5. Imaging Analysis
The gastric MCTS size, solidity, and roundness features were examined using ImageJ image
analysis software with the Fiji image-processing package [48]. First, all images were processed by
color deconvolution “H and E” using the green channel, threshold “minimum” was applied, and all
objects smaller than 62,000 pixels with and without “include holes” were removed. The resulting
mask with “include holes”, which contained a single object, was used to define spheroid size and
roundness by ImageJ’s shape descriptor. The more circular an object, the closer its roundness to 1
was. To define solidity, we divided the area of the mask with “include holes” by the area of mask
without “include holes”. A completely solid object culminated in a value of 1. All masks were saved
and their correctness was confirmed. For ULA plates, pictures of all spheroids were taken, having at
least 3 replicates of each condition. For the 3D Petri Dish®, each condition consisted of one micromold
containing 81 spheroids, and 9 pictures were acquired.
Supplementary Materials: The following are available online.
Molecules 2018, 23, 2815 10 of 12
Author Contributions: Conceptualization, M.B. and C.A.R.; methodology, M.B., S.M., F.D., T.F., and C.C.B.;
software, S.M.; formal analysis, all authors; writing—original draft preparation, M.B., S.M., and C.A.R.;
writing—review and editing, all authors; visualization, M.B. and F.D.; supervision, C.A.R.; project administration
and funding acquisition, M.B., and C.A.R.
Funding: We acknowledge the European Union’s Horizon 2020 research and innovation program under the
Marie Sklodowska-Curie grant agreement No. 748880 awarded to M.B. This work was funded by FEDER
funds through the Operational Program for Competitiveness Factors—COMPETE (POCI-01-0145-FEDER-016585;
POCI-01-0145-FEDER-007274) and National Funds through the Foundation for Science and Technology
(FCT), under the projects: PTDC/BBB-EBI/0567/2014 (to CAR) and UID/BIM/04293/2013; and the project
NORTE-01-0145-FEDER-000029, supported by the North Portugal Regional Program (NORTE 2020) under the
PORTUGAL 2020 Partnership Agreement through the European Regional Development Fund (ERDF).
Acknowledgments: The authors would like to thank Rossana Correia (HEMS, i3S Scientific platform) for support
and discussions on cells processing. We thank Joy Burchell and Joyce Taylor–Papadimitriou for antibodies HMFG1
and HMFG2.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: Globocan
estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 1–31.
[CrossRef] [PubMed]
2. Pampaloni, F.; Reynaud, E.G.; Stelzer, E.H. The third dimension bridges the gap between cell culture and
live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8, 839–845. [CrossRef] [PubMed]
3. Edmondson, R.; Broglie, J.J.; Adcock, A.F.; Yang, L. Three-dimensional cell culture systems and their
applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 2014, 12, 207–218.
[CrossRef] [PubMed]
4. Vinci, M.; Gowan, S.; Boxall, F.; Patterson, L.; Zimmermann, M.; Court, W.; Lomas, C.; Mendiola, M.;
Hardisson, D.; Eccles, S.A. Advances in establishment and analysis of three-dimensional tumor
spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012, 10, 29. [CrossRef]
[PubMed]
5. Lv, D.; Hu, Z.; Lu, L.; Lu, H.; Xu, X. Three-dimensional cell culture: A powerful tool in tumor research and
drug discovery. Oncol. Lett. 2017, 14, 6999–7010. [CrossRef] [PubMed]
6. Patra, B.; Peng, C.C.; Liao, W.H.; Lee, C.H.; Tung, Y.C. Drug testing and flow cytometry analysis on a large
number of uniform sized tumor spheroids using a microfluidic device. Sci. Rep. 2016, 6, 21061. [CrossRef]
[PubMed]
7. Chen, Y.C.; Lou, X.; Zhang, Z.; Ingram, P.; Yoon, E. High-throughput cancer cell sphere formation for
characterizing the efficacy of photo dynamic therapy in 3D cell cultures. Sci. Rep. 2015, 5, 12175. [CrossRef]
[PubMed]
8. Ushiyama, A.; Kataoka, H.; Iijima, T. Glycocalyx and its involvement in clinical pathophysiologies.
J. Intensive Care 2016, 4, 59. [CrossRef] [PubMed]
9. Pinho, S.S.; Reis, C.A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer 2015,
15, 540–555. [CrossRef] [PubMed]
10. Stowell, S.R.; Ju, T.; Cummings, R.D. Protein glycosylation in cancer. Annu. Rev. Pathol. 2015, 10, 473–510.
[CrossRef] [PubMed]
11. Hirschhaeuser, F.; Menne, H.; Dittfeld, C.; West, J.; Mueller-Klieser, W.; Kunz-Schughart, L.A. Multicellular
tumor spheroids: An underestimated tool is catching up again. J. Biotechnol. 2010, 148, 3–15. [CrossRef]
[PubMed]
12. Caldeira, J.; Figueiredo, J.; Bras-Pereira, C.; Carneiro, P.; Moreira, A.M.; Pinto, M.T.; Relvas, J.B.; Carneiro, F.;
Barbosa, M.; Casares, F.; et al. E-cadherin-defective gastric cancer cells depend on laminin to survive and
invade. Hum. Mol. Genet. 2015, 24, 5891–5900. [CrossRef] [PubMed]
13. Jawhari, A.U.; Noda, M.; Farthing, M.J.; Pignatelli, M. Abnormal expression and function of the
e-cadherin-catenin complex in gastric carcinoma cell lines. Br. J. Cancer 1999, 80, 322–330. [CrossRef]
[PubMed]
14. Hollingsworth, M.A.; Swanson, B.J. Mucins in cancer: Protection and control of the cell surface.
Nat. Rev. Cancer 2004, 4, 45–60. [CrossRef] [PubMed]
Molecules 2018, 23, 2815 11 of 12
15. Reis, C.A.; David, L.; Seixas, M.; Burchell, J.; Sobrinho-Simoes, M. Expression of fully and under-glycosylated
forms of muc1 mucin in gastric carcinoma. Int. J. Cancer 1998, 79, 402–410. [CrossRef]
16. Pinto, R.; Carvalho, A.S.; Conze, T.; Magalhaes, A.; Picco, G.; Burchell, J.M.; Taylor-Papadimitriou, J.;
Reis, C.A.; Almeida, R.; Mandel, U.; et al. Identification of new cancer biomarkers based on aberrant mucin
glycoforms by in situ proximity ligation. J. Cell. Mol. Med. 2012, 16, 1474–1484. [CrossRef] [PubMed]
17. Flucke, U.; Steinborn, E.; Dries, V.; Monig, S.P.; Schneider, P.M.; Thiele, J.; Holscher, A.H.; Dienes, H.P.;
Baldus, S.E. Immunoreactivity of cytokeratins (ck7, ck20) and mucin peptide core antigens (muc1, muc2,
muc5ac) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric
junction and proximal stomach. Histopathology 2003, 43, 127–134. [CrossRef] [PubMed]
18. Hutchinson, L.; Kirk, R. High drug attrition rates—Where are we going wrong? Nat. Rev. Clin. Oncol. 2011,
8, 189–190. [CrossRef] [PubMed]
19. Durand, R.E.; Olive, P.L. Resistance of tumor cells to chemo- and radiotherapy modulated by the
three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 2001, 64, 211–233. [PubMed]
20. Pan, T.; Fong, E.L.; Martinez, M.; Harrington, D.A.; Lin, S.H.; Farach-Carson, M.C.; Satcher, R.L.
Three-dimensional (3D) culture of bone-derived human 786-o renal cell carcinoma retains relevant clinical
characteristics of bone metastases. Cancer Lett. 2015, 365, 89–95. [CrossRef] [PubMed]
21. Green, S.K.; Francia, G.; Isidoro, C.; Kerbel, R.S. Antiadhesive antibodies targeting e-cadherin sensitize
multicellular tumor spheroids to chemotherapy in vitro. Mol. Cancer Ther. 2004, 3, 149–159. [PubMed]
22. Longati, P.; Jia, X.; Eimer, J.; Wagman, A.; Witt, M.R.; Rehnmark, S.; Verbeke, C.; Toftgard, R.; Lohr, M.;
Heuchel, R.L. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering
a better model for drug testing. BMC Cancer 2013, 13, 95. [CrossRef] [PubMed]
23. Bauman, E.; Feijao, T.; Carvalho, D.T.O.; Granja, P.L.; Barrias, C.C. Xeno-free pre-vascularized spheroids for
therapeutic applications. Sci. Rep. 2018, 8, 230. [CrossRef] [PubMed]
24. Weaver, V.M.; Lelievre, S.; Lakins, J.N.; Chrenek, M.A.; Jones, J.C.; Giancotti, F.; Werb, Z.; Bissell, M.J. Beta4
integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in
normal and malignant mammary epithelium. Cancer Cell 2002, 2, 205–216. [CrossRef]
25. Fischbach, C.; Chen, R.; Matsumoto, T.; Schmelzle, T.; Brugge, J.S.; Polverini, P.J.; Mooney, D.J. Engineering
tumors with 3D scaffolds. Nat. Methods 2007, 4, 855–860. [CrossRef] [PubMed]
26. Knight, E.; Przyborski, S. Advances in 3D cell culture technologies enabling tissue-like structures to be
created in vitro. J. Anat. 2015, 227, 746–756. [CrossRef] [PubMed]
27. Amado, M.; Carneiro, F.; Seixas, M.; Clausen, H.; Sobrinho-Simoes, M. Dimeric sialyl-le(x) expression in
gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 1998, 114, 462–470.
[CrossRef]
28. Baldus, S.E.; Zirbes, T.K.; Monig, S.P.; Engel, S.; Monaca, E.; Rafiqpoor, K.; Hanisch, F.G.; Hanski, C.;
Thiele, J.; Pichlmaier, H.; et al. Histopathological subtypes and prognosis of gastric cancer are correlated with
the expression of mucin-associated sialylated antigens: Sialosyl-lewis(a), sialosyl-lewis(x) and sialosyl-tn.
Tumour Biol. 1998, 19, 445–453. [CrossRef] [PubMed]
29. Trinchera, M.; Aronica, A.; Dall’Olio, F. Selectin ligands sialyl-lewis a and sialyl-lewis x in gastrointestinal
cancers. Biology 2017, 6, 16. [CrossRef] [PubMed]
30. Fukuda, M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 1996, 56, 2237–2244.
[PubMed]
31. Sotres, J.; Jankovskaja, S.; Wannerberger, K.; Arnebrant, T. Ex-vivo force spectroscopy of intestinal mucosa
reveals the mechanical properties of mucus blankets. Sci. Rep. 2017, 7, 7270. [CrossRef] [PubMed]
32. Coelho, R.; Marcos-Silva, L.; Mendes, N.; Pereira, D.; Brito, C.; Jacob, F.; Steentoft, C.; Mandel, U.; Clausen, H.;
David, L.; et al. Mucins and truncated o-glycans unveil phenotypic discrepancies between serous ovarian
cancer cell lines and primary tumours. Int. J. Mol. Sci. 2018, 19, 2045. [CrossRef] [PubMed]
33. Baldus, S.E.; Engelmann, K.; Hanisch, F.G. Muc1 and the mucs: A family of human mucins with impact in
cancer biology. Crit. Rev. Clin. Lab. Sci. 2004, 41, 189–231. [CrossRef] [PubMed]
34. Kufe, D.W. Mucins in cancer: Function, prognosis and therapy. Nat. Rev. Cancer 2009, 9, 874–885. [CrossRef]
[PubMed]
35. Rachagani, S.; Torres, M.P.; Moniaux, N.; Batra, S.K. Current status of mucins in the diagnosis and therapy of
cancer. Biofactors 2009, 35, 509–527. [CrossRef] [PubMed]
Molecules 2018, 23, 2815 12 of 12
36. Lavrsen, K.; Madsen, C.B.; Rasch, M.G.; Woetmann, A.; Odum, N.; Mandel, U.; Clausen, H.; Pedersen, A.E.;
Wandall, H.H. Aberrantly glycosylated muc1 is expressed on the surface of breast cancer cells and a target
for antibody-dependent cell-mediated cytotoxicity. Glycoconj. J. 2013, 30, 227–236. [CrossRef] [PubMed]
37. Bitler, B.G.; Menzl, I.; Huerta, C.L.; Sands, B.; Knowlton, W.; Chang, A.; Schroeder, J.A. Intracellular muc1
peptides inhibit cancer progression. Clin. Cancer Res. 2009, 15, 100–109. [CrossRef] [PubMed]
38. Hanisch, F.G.; Ninkovic, T. Immunology of o-glycosylated proteins: Approaches to the design of a muc1
glycopeptide-based tumor vaccine. Curr. Protein Pept. Sci. 2006, 7, 307–315. [CrossRef] [PubMed]
39. Motoyama, T.; Hojo, H.; Watanabe, H. Comparison of seven cell lines derived from human gastric carcinomas.
Pathol. Int. 1986, 36, 65–83. [CrossRef]
40. Barranco, S.C.; Townsend, C.M., Jr.; Casartelli, C.; Macik, B.G.; Burger, N.L.; Boerwinkle, W.R.; Gourley, W.K.
Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach.
Cancer Res. 1983, 43, 1703–1709. [PubMed]
41. Park, J.G.; Frucht, H.; LaRocca, R.V.; Bliss, D.P., Jr.; Kurita, Y.; Chen, T.R.; Henslee, J.G.; Trepel, J.B.; Jensen, R.T.;
Johnson, B.E.; et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990,
50, 2773–2780. [PubMed]
42. Mayer, B.; Klement, G.; Kaneko, M.; Man, S.; Jothy, S.; Rak, J.; Kerbel, R.S. Multicellular gastric
cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas.
Gastroenterology 2001, 121, 839–852. [CrossRef] [PubMed]
43. Young, W.W., Jr.; Portoukalian, J.; Hakomori, S. Two monoclonal anticarbohydrate antibodies directed to
glycosphingolipids with a lacto-n-glycosyl type ii chain. J. Biol. Chem. 1981, 256, 10967–10972. [PubMed]
44. Fukushi, Y.; Hakomori, S.; Nudelman, E.; Cochran, N. Novel fucolipids accumulating in human
adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-,
and trifucosylated type 2 chain. J. Biol. Chem. 1984, 259, 4681–4685. [PubMed]
45. Abe, K.; McKibbin, J.M.; Hakomori, S. The monoclonal antibody directed to difucosylated type 2 chain
(fuc alpha 1 leads to 2gal beta 1 leads to 4[fuc alpha 1 leads to 3]glcnac; y determinant). J. Biol. Chem. 1983,
258, 11793–11797. [PubMed]
46. Colcher, D.; Hand, P.H.; Nuti, M.; Schlom, J. A spectrum of monoclonal antibodies reactive with human
mammary tumor cells. Proc. Natl. Acad. Sci. USA 1981, 78, 3199–3203. [CrossRef] [PubMed]
47. Taylor-Papadimitriou, J.; Peterson, J.A.; Arklie, J.; Burchell, J.; Ceriani, R.L.; Bodmer, W.F. Monoclonal
antibodies to epithelium-specific components of the human milk fat globule membrane: Production and
reaction with cells in culture. Int. J. Cancer 1981, 28, 17–21. [CrossRef] [PubMed]
48. Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.;
Saalfeld, S.; Schmid, B.; et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 2012,
9, 676–682. [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
